Clinical Trials Directory

Trials / Completed

CompletedNCT05260060

Youth Metacognitive Therapy Feasibility Trial

Youth Metacognitive Therapy (YoMETA): A Single-Blind Parallel Randomised Feasibility Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
95 (actual)
Sponsor
University of Manchester · Academic / Other
Sex
All
Age
11 Years – 16 Years
Healthy volunteers
Not accepted

Summary

One in eight children and young people (CYP) suffer mental health problems needing support or treatment and 5% have more than one such problem. The effects can be major, affecting CYP emotionally and functionally, impacting progress at school, relationships with others and increasing long term risk of mental health problems. Parents, schools, policy makers and the NHS often struggle to find the best way to help, especially within their limited budgets. The UK Government and the NHS have highlighted the need to improve mental health in CYP. The most common treatment is cognitive behavioural therapy; however this can be time consuming, needs to be delivered over many weeks, must focus on the most upsetting problem first and is not very effective. One way to overcome this is to evaluate a group therapy that can treat multiple mental health problems at once. This new treatment is called Metacognitive Therapy (MCT). The aim of the study is to see if participating in a randomized trial of Group MCT is a feasible and acceptable treatment for CYP suffering with anxiety, stress, depression, or a combination in comparison to usual care. This allows us to test key questions about recruitment and drop-out rates, test the protocol, and gain information about MCT including training and supervision needs of clinicians and the experience of patients receiving it.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTreatment as usual: ControlTreatment usually delivered in service that may include but is not limited to cognitive behaviour therapy, exposure, eye movement desensitisation and reprocessing , behaviour therapy, family therapy.
BEHAVIORALGroup Metacognitive Therapy (Group-MCT): ExperimentalGroup metacognitive therapy (Group-MCT) focuses on developing adaptive control of worry, repetitive negative thinking and attention and modifies beliefs that maintain unhelpful thinking patterns. Treatment is 6 to 8 weekly sessions delivered by two trained mental health professionals, guided by a treatment manual, lasting approximately 90 minutes each session.

Timeline

Start date
2022-05-23
Primary completion
2023-10-19
Completion
2024-04-04
First posted
2022-03-02
Last updated
2024-06-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05260060. Inclusion in this directory is not an endorsement.